Dec 10, 2024
Category
Equity
AUM (Cr.)
208.21
Exit Load (%)
1.00
Min Inv Lumpsum
5,000
Expense Ratio
2.35
Sharpe Ratio
26.50
Beta Ratio
0.00
Fund Manager
Rohan Korde
Inception Date
Nov 08, 2021
Risk Level
Very High
Investment Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.